摘要
目的:观察氢溴酸樟柳碱注射液治疗急性脑梗死的临床疗效。方法:2019年11月-2020年2月收治急性脑梗死患者70例,随机分为两组,各35例。对照组给予常规治疗;观察组在常规治疗基础上加用氢溴酸樟柳碱注射液治疗。比较两组患者美国国立卫生院神经功能缺损量表(NIHSS)及改良Rankin(mRS)评分。结果:观察组治疗1个疗程后NIHSS评分低于对照组,差异有统计学意义(P<0.05)。观察组治疗30 d时mRS评分低于对照组,差异有统计学意义(P<0.05)。结论:氢溴酸樟柳碱注射液治疗急性脑梗死的疗效显著。
Objective:To observe the clinical effect of anisodine hydrobromide injection on acute cerebral infarction.Methods:From November 2019 to February 2020,70 cases of patients with acute cerebral infarction were enrolled,they were randomly divided into two groups with 35 cases in each group.The control group was treated with conventional treatment.The observation group was treated with anisodine hydrobromide injection on the basis of conventional treatment.The NIHSS score and modified Rankin(mRS)scores of the two groups were compared.Results:After one course of treatment,the NIHSS score of observation group was significantly lower than that of control group,the difference was statistically significant(P<0.05).At 30 d of treatment,the mRS score of the observation group was significantly lower than that of the control group,the difference was statistically significant(P<0.05).Conclusion:Anisodine hydrobromide injection is effective in treating acute cerebral infarction.
作者
王利惠
毛伦林
陈文亚
Wang Lihui;Mao Lunlin;Chen Wenya(Wujin Affiliated Hospital of Jiangsu University1,Jiangsu Changzhou 213003;Department of Neurology,Wujin Clinical College of Xuzhou Medical University2,Jiangsu Changzhou 213003)
出处
《中国社区医师》
2020年第31期54-55,共2页
Chinese Community Doctors
